about
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt ...
Read More
0.91
-0.13
(-12.50%)
1.3M
XNAS Volume
XNAS 03 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for IO Biotech Inc is on 12 Nov 2025 for the purpose of IO Biotech Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
IO Biotech Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..